ABSTRACT Aim Respiratory syncytial virus (RSV) infection is a leading cause of paediatric hospitalisations. This study describes annual RSV‐hospitalisation burden of disease, by gestational week of delivery, age and sex among children aged 0–17 years of age in Sweden, for the period 2010/11–2021/22.
Kristian Bolin +4 more
wiley +1 more source
Epidemiological trends and seasonality of respiratory syncytial virus infection in children based on sentinel hospital surveillance data. [PDF]
Hu Z +5 more
europepmc +1 more source
Uptake and predictors of newborn respiratory syncytial virus (RSV) immunisation with nirsevimab in Ireland's national pilot programme: a cross-sectional study. [PDF]
Masukume G +10 more
europepmc +1 more source
ABSTRACT After introducing nirsevimab during the 2024/2025 respiratory syncytial virus (RSV) season in Germany, RSV activity in infants under 1 year dropped by 50% in primary care and 50%–70% in secondary care. Inpatients under 6 months showed the greatest reduction.
Wei Cai +14 more
wiley +1 more source
Avena sativa-derived avenanthramides suppress 12-lipoxygenase activity and downstream arachidonic acid metabolites in letrozole-induced PCOS rats. [PDF]
Walid Y +3 more
europepmc +1 more source
Etiology and Epidemiology of Acute Lower Respiratory Infections Among Hospitalized Pediatric Patients in Northeastern China: A Retrospective Study from 2023 to 2025. [PDF]
Zhao HY +4 more
europepmc +1 more source
ABSTRACT Our study aimed to investigate the effects of Triacetyl resveratrol (TCRV) on epithelial‐mesenchymal transition (EMT) in human lung cancer cell lines. Different concentrations of TCRV were applied to the A549 cell line for 24 and 48 h. The IC50 value of TCRV was determined by cell viability with the CCK‐8 test.
Nihal Üren +4 more
wiley +1 more source
Bivalent RSV Prefusion F Protein-Based Vaccine Effectiveness in Individuals With and Without Diabetes: A Prespecified Analysis of the DAN-RSV Trial. [PDF]
Pareek M +34 more
europepmc +1 more source

